QNRX

QuoinC

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-18

View Chart

Current thesis

Composite grade C from latest DB weights. Momentum 38.9 / Value 57.8

Posture

Mixed

Lead driver

Value

What changed

Value remains the lead driver in the composite, 7D delta -0.3.

What can break

Mixed signals. Wait for cleaner trend confirmation.

Momentum

Value

Sentiment

N/A

Setup hits (3d)

— · Net —

AI TargetsBase - · Bull - · Bear -

Data freshness

Prices

As of 2026-07-18

Fundamentals

As of 2026-07-17 • Vendor: Data Vendor v1

Scores

As of 2026-07-18 • Model: HYBRID_IC_RP

AI Memo

Unavailable: No memo yet

Investment thesis

As of 2026-07-18

Supporting evidence

What

Grade C · Mixed

Confidence Medium · Net —

Target $21.40

Why

Momentum39 · Δ7d -

Value58 · Δ7d -0.3

SentimentN/A · Δ7d -

So what

Balanced signals. Wait for confirmation before sizing up.

Setup hits not loaded

Load setup hits to see net bias and recent triggers.

Load setup hits

Lead driver: Value · See fundamentals

Momentum

40% active weight

Current posture

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Value

60% active weight

Current posture

7d trendFlat

Δ7d

-0.3

Δ21d

-0.2

Sentiment

N/A

Coverage pending

No current score

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Why this grade

Composite grade C. Momentum 38.9 / Value 57.8

Fundamentals (TTM)

As of 2026-07-17

Market Cap

$8.32M

Beta

1.69

Shares Out

1.96M

P/E (TTM) · Derived

-0.4

P/S (TTM)

P/FCF (TTM) · Derived

-0.02

Rev YoY

EPS YoY

-98.9%

Gross Margin

Op Margin

Net Debt

-$18.75M

Current Ratio

2.87

As of 2026-07-18 • Updated nightlySource: Internal modelMethodology